On June 25, Everyday Health quoted Alyssa Dominguez, MD, endocrinologist with Keck Medicine and clinical assistant professor of medicine (clinician educator), on a study associating semaglutide use with reduced risk of major kidney disease-related events in people with Type 2 diabetes.
USC launches large-scale nationwide study of type 1 diabetes and brain development, led by Co-Director of DORI
“With a $2.7 million grant from the National Institutes of Health, researchers from the Keck School of Medicine of USC will lead a multi-site study to understand and optimize brain
